TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis

Overview of attention for article published in BMC Neurology, June 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 3 news outlets

twitter: 4 X users

Citations

dimensions_citation: 65 Dimensions

Readers on

mendeley: 145 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Biomarker Discovery: Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Clinical Advisor, 13 Oct 2022

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) were traditionally considered 2 different neurologic…

Biomarker Discovery: Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Neurology Advisor , 19 Aug 2022

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) were traditionally considered 2 different neurologic…

TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.

Alzforum, 06 Jul 2018

. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.